|
業務類別
|
Biotechnology |
|
業務概覽
|
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation. |
| 公司地址
| 201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA, USA, 92075 |
| 電話號碼
| +1 858 925-7000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.lenz-tx.com |
| 員工數量
| 152 |
| Mr. Daniel R. Chevallard |
Chief Financial Officer and Principal Accounting Officer |
-- |
28/04/2026 |
| Mr. Evert B. Schimmelpennink |
Director, President, Chief Executive Officer and Secretary |
美元 690.00K |
28/04/2026 |
| Mr. Shawn Olsson |
Chief Commercial Officer |
美元 467.50K |
28/04/2026 |
| Dr. Marc Odrich, M.D. |
Chief Medical Officer |
美元 500.00K |
28/04/2026 |
|
|
| Ms. Shelley B. Thunen |
Independent Director |
28/04/2026 |
| Dr. Kimberlee Cobleigh Drapkin, PhD |
Independent Director |
28/04/2026 |
| Mr. Jeffrey P. George |
Chairperson of the Board |
28/04/2026 |
| Mr. Evert B. Schimmelpennink |
Director, President, Chief Executive Officer and Secretary |
28/04/2026 |
| Dr. Frederic Guerard, Pharm.D. |
Independent Director |
28/04/2026 |
| Mr. James McCollum, M.D. |
Independent Director |
28/04/2026 |
|
|
|
|
